Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Share News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 116.50
Bid: 115.00
Ask: 118.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.609%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 116.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Transense Tech, Hightex, Verona Pharma

Tue, 28th Aug 2012 14:43

Transense Technologies, which provides sensor systems for the transportation and industrial markets, has reported that its trading division, Translogik, has received an initial order for its iTrack Tyre Temperature and Pressure Monitoring Systems for mining and off-the-road vehicles from its Indonesian distributor, AutoRFID Solutions. The system will be installed as part of a pilot scheme on three of the 168 vehicles at the ADARO mine in Indonesia, one of AutoRFID's clients. Graham Storey, Chief Executive Officer of Transense, said it is "very encouraging that our success in South Africa has triggered this order in what is a new territory for us".Hightex Group, a systems engineering company, has been selected, along with its Brazilian construction partner SEPA, to engineer and install the membrane structure of the roof of the Beira-Rio Stadium in Porto Alegre, a 2014 FIFA World Cup venue. The deal, which has a value in the region of €10m, marks the firm's second contract win in Brazil. The stadium is the fifth largest in Brazil, and will accommodate around 50,000 spectators. Work will begin immediately and is due to be completed in 2013. Verona Pharma, a drug discovery company, has been granted a new patent for its lead drug candidate, RPL554, in the US. The product is being developed for the treatment of patients with chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. The company is currently carrying out clinical trials of the drug to further characterise its bronchodilator and anti-inflammatory effects. NR
More News
2 Mar 2016 08:37

Transense Technologies Short-Term Outlook Cautious, Swings To Profit

Read more
16 Dec 2015 08:07

Transense Technologies Wins Tyre Probe Contract With Continental

Read more
16 Nov 2015 09:40

Transense Technologies Sees Improvements In Sales Pipeline

Read more
9 Nov 2015 16:16

AGM, EGM Calendar - Week Ahead

Read more
29 Oct 2015 10:11

DIRECTOR DEALINGS: Surgical Innovations New Chairman Buy First Shares

Read more
28 Oct 2015 08:52

Surgical Innovations Appoints Nigel Rogers Executive Chairman

Read more
22 Oct 2015 08:46

DIRECTOR DEALINGS: Transense Deputy Chairman Buys 1 Million Shares

Read more
21 Oct 2015 09:43

WINNERS & LOSERS SUMMARY: ARM, Merlin And Sky Lead Blue-Chip Gainers

Read more
21 Oct 2015 09:39

Transense Technology surges after selling loss-making division

(ShareCast News) - Shares in Transense Technologies surged over 25% on Wednesday, after the technical research provider revealed it has agreed to sell its loss-making IntelliSAW division. The London-listed company has reached a deal with US-based manufacturer Emerson Electric, which will see it rece

Read more
21 Oct 2015 08:07

Transense Technologies Sells Loss-Making IntelliSAW Unit To Emerson

Read more
28 Sep 2015 08:57

Transense Technologies Hit By Mining Market Contraction, Loss Widens

Read more
13 Aug 2015 06:52

Transense Technologies Wins Further Australian Mining Contract

Read more
27 Jul 2015 09:05

Transense Sees Full-Year In Line, Remains In IntelliSAW Sale Talks

Read more
29 Jun 2015 11:07

LONDON MARKET MIDDAY: Grexit Worries Sink Global Equities Markets

Read more
29 Jun 2015 09:54

WINNERS & LOSERS: Safe Haven Demand Sends Gold Miners Higher

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.